Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

What to Expect From Bio-Techne's Next Quarterly Earnings Report

With a market cap of $11.3 billion, Bio-Techne Corporation (TECH) is a global life sciences company that develops, manufactures, and sells reagents, instruments, and services for research, diagnostics, and bioprocessing applications. It operates through its Protein Sciences and Diagnostics and Spatial Biology segments, providing innovative solutions for life science research, cell and gene therapy, molecular diagnostics, and spatial biology.

The Minneapolis, Minnesota-based company is slated to announce its fiscal Q4 2026 results soon. Ahead of the event, analysts expect TECH to report an EPS of $0.46, down 9.8% from $0.51 in the year-ago quarter. However, it has surpassed or met Wall Street's bottom-line estimates in each of the past four quarterly reports.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.